With its coronavirus vaccine expected to be ready in the coming months, absent a setback, Pfizer Inc. already is discussing orders for what could be a massive commercial opportunity.
Pfizer Chairman and CEO Albert Bourla said 26 June that he remains cautiously optimistic the COVID-19 vaccine program will be successful and that
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?